Company intelligence / Profile preview

MPM BioEquities Adviser

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

MPM BioEquities is the public equity investment arm of MPM BioImpact (formerly MPM Capital), a leading biotechnology investment firm. The group focuses on investing in publicly traded life sciences companies, leveraging deep scientific and clinical expertise to identify value in innovative drug development and healthcare technologies. By maintaining a specialized focus on the biotech sector, MPM BioEquities aims to capture growth from breakthrough medical advancements and clinical milestones. The firm operates as an advisory entity managing dedicated funds that complement MPM's long-standing venture capital and impact investing strategies.

Industry: Investors

Beyond the preview

Go deeper on MPM BioEquities Adviser.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MPM BioEquities Adviser.

Explore the full profile